This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
TPI Composites (TPIC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
TPI Composites (TPIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TPI Composites (TPIC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
TPI Composites (TPIC) delivered earnings and revenue surprises of 3.09% and 1.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Constellium (CSTM) Q4 Earnings Miss Estimates
by Zacks Equity Research
Constellium (CSTM) delivered earnings and revenue surprises of -68.42% and 15.82%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: TPI Composites (TPIC) Q4 Earnings Expected to Decline
by Zacks Equity Research
TPI Composites (TPIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: TPI Composites (TPIC) Q3 Earnings Expected to Decline
by Zacks Equity Research
TPI Composites (TPIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Stoneridge, Illumina, TPI Composites and JD.com
by Zacks Equity Research
Zacks.com featured highlights include: Stoneridge, Illumina, TPI Composites and JD.com
Let Go of These 4 Toxic Stocks Right Away
by Rimmi Singhi
Steer clear of toxic stocks like SRI, ILMN, TPIC and JD to safeguard your portfolio from losses.
Zacks.com featured highlights include: TPI Composites, Cameco Corp, Hexcel Corp and Viad Corp
by Zacks Equity Research
Zacks.com featured highlights include: TPI Composites, Cameco Corp, Hexcel Corp and Viad Corp
4 Toxic Stocks That Don't Deserve a Place in Your Portfolio
by Rimmi Singhi
Investors who can correctly spot the overpriced toxic stocks and shun them at the right time are the ones likely to make a profit.
TPI Composites (TPIC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
TPI Composites (TPIC) delivered earnings and revenue surprises of -5.26% and 0.01%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Will TPI Composites (TPIC) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
TPI Composites (TPIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TPI Composites (TPIC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
TPI Composites (TPIC) delivered earnings and revenue surprises of 72.22% and -0.95%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
TPI Composites (TPIC) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TPI Composites (TPIC) delivered earnings and revenue surprises of 165.38% and 6.09%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
TPI Composites (TPIC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
TPI Composites (TPIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Axon Enterprise (AAXN) Q2 Earnings?
by Zacks Equity Research
Axon Enterprise's (AAXN) second-quarter results are likely to reflect strong demand for TASER 7 device, Axon Cloud software offerings and Axon Body 3.
TPI Composites (TPIC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
TPI Composites (TPIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
O-I Glass (OI) Declines 21% YTD: What's Hurting the Stock?
by Zacks Equity Research
The coronavirus pandemic has impacted customer demand, which is likely to weigh on O-I Glass' (OI) volumes in the current year.
Pentair Rides on Investments & Acquisitions Amid Weak Demand
by Zacks Equity Research
Pentair (PNR) likely to benefit from investments in water treatment solutions, productivity improvement and cost-control initiatives amid weak demand due to the coronavirus crisis.
Lindsay Buys Net Irrigate, Expands Remote Monitoring Solution
by Zacks Equity Research
Net Irrigate and Lindsay's (LNN) FieldNET brand of remote irrigation monitoring and control solutions to enable growers implement sustainable farming practices.
Dismal End-Market Demand & Cost Woes Impact AptarGroup
by Zacks Equity Research
AptarGroup's (ATR) Q2 performance might have been adversely impacted by lackluster demand due to the coronavirus crisis-related near-term uncertainties.
4 Manufacturing Stocks to Buy As They Rebound
by Manaswita Ghosh Dutta
Manufacturing activity is increasing in the country despite the number of new COVID-19 cases, pointing at a recovering U.S. economy.
Lindsay (LNN) Q3 Earnings Beats Estimates, Revenues In Line
by Zacks Equity Research
Lindsay (LNN) reports better-than-expected earnings for third-quarter fiscal 2020, driven by the Foundation for Growth initiative.
U.S. Manufacturing Rebounds in June: 4 Industrial Stocks to Buy
by Namrata Chatterjee
As the U.S. manufacturing sector shows signs of recovery, we suggest four promising industrial stocks with positive growth projections for your portfolio.
4 Industrial Stocks to Have Outperformed the S&P 500 YTD
by Zacks Equity Research
Despite a disappointing Industrial Products sector's performance, year to date, these four industrial stocks have outshone the S&P 500 and seem poised for a solid finish this year.
Here's Why You Should Consider Buying SiteOne Landscape Stock
by Zacks Equity Research
SiteOne Landscape (SITE) is likely to gain from solid product offerings, value-added services and buyouts. Also, cost-saving measures and deleveraging actions along with healthy liquidity might help deal with the pandemic woes.